Methods, systems, and kits for the treatment of inflammatory diseases by targeting TL1A

JP2026519500APending Publication Date: 2026-06-16PROMETHEUS BIOSCIENCES INC
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
PROMETHEUS BIOSCIENCES INC
Filing Date
2024-05-24
Publication Date
2026-06-16

Smart Images

  • Figure 2026519500000001_ABST
    Figure 2026519500000001_ABST
Patent Text Reader

Abstract

Methods, systems, and kits are provided for selecting targets for treatment with inhibitors of tumor necrosis factor-like cytokine 1A (TL1A) activity or expression, based on the ratio of TL1A isoforms.
Need to check novelty before this filing date? Find Prior Art